Company intelligence / Profile preview

PNQ Health

Minneapolis, Minnesota, United Statespnqhealth.com ↗

Ownership: Private
Development stage: Commercial

Overview

PNQ Health has received FDA clearance for its Class II Software as a Medical Device designed to treat tinnitus. The solution integrates signal monitoring, internal medicine consultation via telemedicine, and individualized protocols enhanced by machine learning. The approach is non-invasive, self-administered under clinical supervision, and supported by ongoing development of clinical data/outcomes databases. No traditional drug or device pipeline exists beyond this core offering.

Therapeutic areas: Neurology
Modalities: Software as a Medical DeviceDigital therapeutic
Industry: Digital Health Medical Devices

Partnerships

Seeking strategic partners/investors; none named yet

Beyond the preview

Go deeper on PNQ Health.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PNQ Health.

Explore the full profile